ConductScience.org, home

Paper53727

Intraportal insulin protects from the liver injury of portacaval shunt in dogs.

Starzl TE and 2 others. Lancet, 1975. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Papers, record 53727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53727

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
2.32
iCite
Revised in PubMed
2019-06-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Starzl TET E
2Porter KAK A
3Putnam CWC W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InsulinMajor topic
Liver DiseasesMajor topic
Portacaval Shunt, SurgicalMajor topic
Portal VeinMajor topic
Postoperative ComplicationsMajor topic
Animals
Atrophy
Dogs
Infusions, Parenteral
Liver
Microscopy, Electron

Source PubMed

Download CSV of topics

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
41109800Systemic and metabolic control of liver regeneration.Trends Endocrinol Metab2026https://conductscience.org/library/papers/41109800PubMed
39920130Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39920130PubMed
32542223Hormonal Contribution to Liver Regeneration.Mayo Clin Proc Innov Qual Outcomes2020https://conductscience.org/library/papers/32542223PubMed
24139945Elucidating the metabolic regulation of liver regeneration.Am J Pathol2014https://conductscience.org/library/papers/24139945PubMed
23073658Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies.Mol Med2013https://conductscience.org/library/papers/23073658PubMed
20235333Themes of liver transplantation.Hepatology2010https://conductscience.org/library/papers/20235333PubMed
16937489Insights on augmenter of liver regeneration cloning and function.World J Gastroenterol2006https://conductscience.org/library/papers/16937489PubMed
16447295The unfinished legacy of liver transplantation: emphasis on immunology.Hepatology2006https://conductscience.org/library/papers/16447295PubMed
12175629Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.J Hepatol2002https://conductscience.org/library/papers/12175629PubMed
10833242History of clinical transplantation.World J Surg2000https://conductscience.org/library/papers/10833242PubMed
10216127A fresh look at augmenter of liver regeneration in rats.Hepatology1999https://conductscience.org/library/papers/10216127PubMed
10148367Cellular transplantation and gene therapy.Clin Transplant1993https://conductscience.org/library/papers/10148367PubMed
9934824Role of shear stress and immune responses in liver regeneration after a partial hepatectomy.Surg Today1999https://conductscience.org/library/papers/9934824PubMed
9786582Successful surgical treatment for hepatic encephalopathy caused by a pancreatic siphon: report of a case.Surg Today1998https://conductscience.org/library/papers/9786582PubMed
9457961The mother lode of liver transplantation, with particular reference to our new journal.Liver Transpl Surg1998https://conductscience.org/library/papers/9457961PubMed
9021955The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions.Hepatology1997https://conductscience.org/library/papers/9021955PubMed
7429306Evidence for liver cell proliferation during fatal acute liver failure.Gut1980https://conductscience.org/library/papers/7429306PubMed
7000878Insulin secretion and carbohydrate metabolism in experimental protein malnutrition.J Endocrinol Invest1980https://conductscience.org/library/papers/7000878PubMed
6357642The Eck fistula in animals and humans.Curr Probl Surg1983https://conductscience.org/library/papers/6357642PubMed
3549508Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants.Hepatology1987https://conductscience.org/library/papers/3549508PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/53727

GET https://conductscience.org/api/papers/v1/53727/cited_by?page=2